1-(5-isoquinolinesulfonyl)-2-methylpiperazine and thromboxanes

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with thromboxanes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; Alam, F; Blood, AB; Giri, PC; Hanson, SFL; Moretta, DT; Power, GG; Terry, MH; Wilson, SM1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and thromboxanes

ArticleYear
Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Inhalation; Aerosols; Animals; Animals, Newborn; Antihypertensive Agents; Arterial Pressure; Cardiac Output; Disease Models, Animal; Female; Heart Rate; Hypertension, Pulmonary; Infusions, Intravenous; Male; Protein Kinase Inhibitors; Pulmonary Artery; rho-Associated Kinases; Sheep, Domestic; Thromboxanes; Vascular Resistance; Vasodilator Agents

2018